Human papillomavirus E6 triggers upregulation of the antiviral and cancer genomic DNA deaminase APOBEC3B

Keyphrases

• High-risk Human Papillomavirus (HR-HPV) 100%
• Genomic DNA (gDNA) 100%
• APOBEC3B 100%
• DNA Deaminase 100%
• Cancer Genomics 100%
• Tumor Protein p53 (TP53) 25%
• Head-and-neck Cancer 16%
• High Risk 16%
• Innate Immune Response 16%
• Functional Inactivation 16%
• E6 Protein 16%
• Antiviral Activity 8%
• Lung 8%
• Head-and-neck 8%
• Breast Cancer 8%
• Papillomavirus Infections 8%
• Human Cancer 8%
• Breast 8%
• MRNA Expression 8%
• Mutagenesis 8%
• DNA Cytosine Deaminase 8%
• Cervical Cancer 8%
• Low Risk 8%
• Enzymatic Activity 8%
• Bladder 8%
• Cancer Data 8%
• Non-cancer 8%
• Multiple Systems 8%
• Derepression 8%
• Knockdown 8%
• Gene Transcription 8%
• Cytosine 8%
• Tumor Subtype 8%
• Publicly Available 8%
• Multiple Persons 8%
• Cervix 8%
• Mutator Phenotype 8%
• Mutation Bias 8%
• Genomic Uracil 8%
• E6 Oncoprotein 8%
• Expression Activity 8%
• Human Papillomavirus Negative 8%
• Genetic Inactivation 8%

Immunology and Microbiology

• Wart Virus 100%
• Upregulation 100%
• Neck 37%
• Innate Immune System 12%
• Cell Line 12%
• Ovary 12%
• Enzyme Activity 12%
• Genetic Transfection 12%
• Genetic Transcription 12%
• Antiviral Activity 12%
• Mutagenesis 12%